Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-07

FDA Approved: ARSENIC TRIOXIDE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved the Original Application (ANDA) for arsenic trioxide from Sagent Pharmaceuticals, enabling a generic version of the cancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arsenic Trioxide (arsenic trioxide)

Snippet

ORIG AP for ARSENIC TRIOXIDE (ARSENIC TRIOXIDE)